Skip to main content

01.08.2006 | Original Paper

The Efficacy of an Herbal Medicine, Carmint, on the Relief of Abdominal Pain and Bloating in Patients with Irritable Bowel Syndrome: A Pilot Study

verfasst von: Reyhaneh Vejdani, Hamid Reza Mohaghegh Shalmani, Mina Mir-Fattahi, Faranak Sajed-Nia, Morteza Abdollahi, Mohammad Reza Zali, Amir Houshang Mohammad Alizadeh, Ali Bahari, Gholamreza Amin

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Carmint contains total extracts of Melissa officinalis, Mentha spicata, and Coriandrum sativum, which have antispasmodic, carminative, and sedative effects. As abdominal pain/discomfort and bloating are commonly observed in patients with irritable bowel syndrome, we decided to evaluate the effectiveness of Carmint in relieving these symptoms in irritable bowel syndrome patients. We randomly assigned 32 irritable bowel syndrome patients to receive either Carmint or placebo, plus Loperamide or psyllium (based on their predominant bowel function), for 8 weeks. T-test analysis of the results showed that the severity and frequency of abdominal pain/discomfort were significantly lower in the Carmint group than the placebo group at the end of the treatment (P=0.016 and P=0.001, respectively), as were the severity and frequency of bloating (P=0.02 and P=0.002, respectively). This pilot study suggests that Carmint plus loperamide or Carmint plus psyllium (depending on the irritable bowel syndrome subtype) might be effective in these patients.
Literatur
1.
Zurück zum Zitat Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45:43–47 Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45:43–47
2.
Zurück zum Zitat Watson AR, Bowling TE (2005) Irritable bowel syndrome: diagnosis and symptom management. Br J Commun Nurs 10:118–122 Watson AR, Bowling TE (2005) Irritable bowel syndrome: diagnosis and symptom management. Br J Commun Nurs 10:118–122
3.
Zurück zum Zitat Whitehead WE (1999) Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination. Am J Med 107:33–40CrossRef Whitehead WE (1999) Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination. Am J Med 107:33–40CrossRef
4.
Zurück zum Zitat Talley NJ, Zinsmeister AR, Melton J (1995) Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142:76–83PubMed Talley NJ, Zinsmeister AR, Melton J (1995) Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142:76–83PubMed
5.
Zurück zum Zitat Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 128:580–589PubMedCrossRef Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 128:580–589PubMedCrossRef
6.
Zurück zum Zitat Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, Guthrie E, Read N, Thompson D (2001) Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134:860–868PubMed Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, Guthrie E, Read N, Thompson D (2001) Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134:860–868PubMed
7.
Zurück zum Zitat Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG (1993) US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569–1580PubMedCrossRef Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG (1993) US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569–1580PubMedCrossRef
8.
Zurück zum Zitat Heaton KW, O’Donnell LJD, Braddon FEM, Moutford RA, Hughes AO, Cripps PJ (1992) Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 102:1962–1967PubMed Heaton KW, O’Donnell LJD, Braddon FEM, Moutford RA, Hughes AO, Cripps PJ (1992) Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 102:1962–1967PubMed
9.
Zurück zum Zitat Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG (1995) Comparison of bowel patterns in Hispanic and non-Hispanic whites. Dig Dis Sci 40:1761–1769 Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG (1995) Comparison of bowel patterns in Hispanic and non-Hispanic whites. Dig Dis Sci 40:1761–1769
10.
Zurück zum Zitat Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroentroenterol Hepatol 7:427–433 Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroentroenterol Hepatol 7:427–433
11.
Zurück zum Zitat Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA (2000) (C) Functional bowel disorders and (D) functional abdominal pain. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 351–432 Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA (2000) (C) Functional bowel disorders and (D) functional abdominal pain. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 351–432
12.
Zurück zum Zitat Jarrett M, Heitkemper MM, Bond EF, Georges J (1994) Comparison of diet composition in women with and without functional bowel disorder. Gastroenterol Nurs 6:253CrossRef Jarrett M, Heitkemper MM, Bond EF, Georges J (1994) Comparison of diet composition in women with and without functional bowel disorder. Gastroenterol Nurs 6:253CrossRef
13.
Zurück zum Zitat Distrutti E, Azpiroz F, Soldevilla A, Malagelada JR (1999) Gastric wall tension determines perception of gastric distention. Gastroenterology 116:1035–1042PubMedCrossRef Distrutti E, Azpiroz F, Soldevilla A, Malagelada JR (1999) Gastric wall tension determines perception of gastric distention. Gastroenterology 116:1035–1042PubMedCrossRef
14.
Zurück zum Zitat Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116:573–585PubMedCrossRef Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116:573–585PubMedCrossRef
15.
Zurück zum Zitat Malcolm A, Phillips SF, Camilleri M, Hanson RB (1997) Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 92:2073–2079PubMed Malcolm A, Phillips SF, Camilleri M, Hanson RB (1997) Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 92:2073–2079PubMed
16.
Zurück zum Zitat Cann PA, Read NW, Holdsworth CD (1984) What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 25:168–173PubMedCrossRef Cann PA, Read NW, Holdsworth CD (1984) What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 25:168–173PubMedCrossRef
17.
Zurück zum Zitat Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA (1997) Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 92:95–98PubMed Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA (1997) Clinical response to dietary fiber treatment of chronic constipation. Am J Gastroenterol 92:95–98PubMed
18.
Zurück zum Zitat Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC (1992) Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 67:725–731PubMed Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC (1992) Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 67:725–731PubMed
19.
Zurück zum Zitat Cann PA, Read NW, Holdsworth CD, Barends D (1984) Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 29:239–247PubMedCrossRef Cann PA, Read NW, Holdsworth CD, Barends D (1984) Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 29:239–247PubMedCrossRef
20.
Zurück zum Zitat Camilleri M (1999) Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 107(5A):27S–32SPubMedCrossRef Camilleri M (1999) Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 107(5A):27S–32SPubMedCrossRef
21.
Zurück zum Zitat Fleming T (2000) PDR for herbal medicines, 2nd ed. Medical Economics Fleming T (2000) PDR for herbal medicines, 2nd ed. Medical Economics
22.
Zurück zum Zitat Ballard C, O’Brien J, Reichelt K, Perry E (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 63:553–558PubMed Ballard C, O’Brien J, Reichelt K, Perry E (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 63:553–558PubMed
23.
Zurück zum Zitat Sweetman SC (2005) Martindale, the complete drug reference, 34th ed. Pharmaceutical Press, p 1749 Sweetman SC (2005) Martindale, the complete drug reference, 34th ed. Pharmaceutical Press, p 1749
24.
Zurück zum Zitat Drossman DA (2000) The functional gastrointestinal disorders, their diagnosis and the Rome II process. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 1–29 Drossman DA (2000) The functional gastrointestinal disorders, their diagnosis and the Rome II process. In: Drossman DA, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Rome II: The functional gastrointestinal disorders: Diagnosis, pathophysiology and treatment. A multinational consensus, 2nd ed. Degnon Associates, McLean, VA, pp 1–29
25.
Zurück zum Zitat Quartero A, Meineche-Schmidt V, Muris J, Rubin G, de Wit N (2005) Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 18:CD003460 Quartero A, Meineche-Schmidt V, Muris J, Rubin G, de Wit N (2005) Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 18:CD003460
26.
Zurück zum Zitat De Ponti R, Malagelada JR (1998) Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharm Ther 80(1):49–88CrossRef De Ponti R, Malagelada JR (1998) Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharm Ther 80(1):49–88CrossRef
27.
Zurück zum Zitat Dew MJ, Evans BK, Rhodes J (1984) Peppermint oil for the irritable bowel syndrome: A multicentre trial. Br J Clin Pract 38:394 –398PubMed Dew MJ, Evans BK, Rhodes J (1984) Peppermint oil for the irritable bowel syndrome: A multicentre trial. Br J Clin Pract 38:394 –398PubMed
28.
Zurück zum Zitat Rees WDW, Evans BK, Rhodes J (1979) Treating the irritable bowel syndrome with peppermint oil. Br Med J 2:835–836PubMedCrossRef Rees WDW, Evans BK, Rhodes J (1979) Treating the irritable bowel syndrome with peppermint oil. Br Med J 2:835–836PubMedCrossRef
Metadaten
Titel
The Efficacy of an Herbal Medicine, Carmint, on the Relief of Abdominal Pain and Bloating in Patients with Irritable Bowel Syndrome: A Pilot Study
verfasst von
Reyhaneh Vejdani
Hamid Reza Mohaghegh Shalmani
Mina Mir-Fattahi
Faranak Sajed-Nia
Morteza Abdollahi
Mohammad Reza Zali
Amir Houshang Mohammad Alizadeh
Ali Bahari
Gholamreza Amin
Publikationsdatum
01.08.2006
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2006
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9079-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.